株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

癌栄養学の世界市場 - 2023年:頭頚部癌・胃&消化器癌・肝臓癌・膵臓癌・食道癌・肺癌・乳癌・血液癌

Oncology Nutrition Market by Cancer Type (Head & Neck, Stomach & Gastrointestinal, Liver, Pancreatic, Esophageal, Lung, Breast, Blood) - Global Forecast to 2023

発行 MarketsandMarkets 商品コード 633086
出版日 ページ情報 英文 97 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.97円で換算しております。
Back to Top
癌栄養学の世界市場 - 2023年:頭頚部癌・胃&消化器癌・肝臓癌・膵臓癌・食道癌・肺癌・乳癌・血液癌 Oncology Nutrition Market by Cancer Type (Head & Neck, Stomach & Gastrointestinal, Liver, Pancreatic, Esophageal, Lung, Breast, Blood) - Global Forecast to 2023
出版日: 2018年04月30日 ページ情報: 英文 97 Pages
概要

癌栄養学市場は、2018年の14億6,000万米ドルから、2023年までに22億1,000万米ドルまで拡大すると見られ、予測期間中のCAGR (複合年間成長率) は、8.9%の成長が予測されています。市場の全体的な成長は主に、非経口から経腸栄養へのフォーカスの変化、癌発症率の増加、在宅部門における栄養摂取の需要の高まり、栄養不良の治療を受ける患者数の増加、および栄養学的介入に関する臨床研究の品質の向上に促進されています。消化態栄養剤の開発および同分野における製品革新も、同市場における大幅な成長機会を提供しています。しかし、経管栄養法に関連した合併症および医療費償還の制限は、癌栄養学市場の成長に大きな課題を提供しています。

当レポートでは、世界の癌栄養学市場について調査分析し、市場概要、産業動向、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

第1章 イントロダクション

第2章 調査手法

第3章 市場力学

  • 促進要因
  • 抑制要因
  • 機会

第4章 重要考察

  • 臨床課題
  • 市場課題
  • 製品特徴の評価
  • 産業専門家の考察

第5章 世界の癌栄養剤市場:癌タイプ別

  • 概要:癌
  • 市場規模:癌タイプ別
  • 頭頚部癌
  • 胃・消化器癌
  • 肝臓癌
  • 膵臓癌
  • 食道癌
  • 肺癌
  • 乳癌
  • 血液癌
  • その他の癌

第6章 製品ポートフォリオ評価

第7章 企業プロファイル

  • ABBOTT LABORATORIES
  • NESTLE
  • DANONE
  • FRESENIUS KABI
  • B. BRAUN

第8章 市場シェア分析

図表

LIST OF TABLES

  • TABLE 1: GLOBAL ONCOLOGY NUTRITIONAL FEEDING FORMULAS MARKET, BY CANCER TYPE, 2016-2023 (USD MILLION)
  • TABLE 2: GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 3: GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET FOR HEAD & NECK CANCERS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 4: GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET FOR STOMACH & GASTROINTESTINAL CANCERS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 5: GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET FOR LIVER CANCER, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 6: GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET FOR PANCREATIC CANCER, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 7: GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET FOR ESOPHAGEAL CANCER, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 8: GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET FOR LUNG CANCER, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 9: GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET FOR BREAST CANCER, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 10: GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET FOR BLOOD CANCER, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 11: GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET FOR OTHER CANCERS, BY COUNTRY, 2016-2023 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: GLOBAL CANCER INCIDENCE, 2008-2030
  • FIGURE 2: CANCER INCIDENCE ACROSS KEY COUNTRIES, 2012
  • FIGURE 3: SHARE OF GERIATRIC POPULATION AMONG NEW CANCER CASES
  • FIGURE 4: SMOKING PREVALENCE, BY COUNTRY, 2015 (% OF TOTAL POPULATION)
  • FIGURE 5: ESTIMATED NUMBER OF NEW CANCER CASES
  • FIGURE 6: GLOBAL ONCOLOGY NUTRITIONAL FEEDING FORMULAS MARKET, BY CANCER TYPE, 2018 VS 2023
  • FIGURE 7: HEAD & NECK CANCERS INCIDENCE, 2012-2030
  • FIGURE 8: HEAD & NECK CANCERS INCIDENCE ACROSS KEY REGIONS, 2012
  • FIGURE 9: STOMACH CANCER INCIDENCE, 2012-2030
  • FIGURE 10: STOMACH CANCER INCIDENCE ACROSS KEY REGIONS, 2012
  • FIGURE 11: LIVER CANCER INCIDENCE, 2012-2030
  • FIGURE 12: LIVER CANCER INCIDENCE ACROSS KEY REGIONS, 2012
  • FIGURE 13: PANCREATIC CANCER INCIDENCE, 2012-2030
  • FIGURE 14: PANCREATIC CANCER INCIDENCE ACROSS KEY REGIONS, 2012
  • FIGURE 15: ESOPHAGEAL CANCER INCIDENCE, 2012-2030
  • FIGURE 16: ESOPHAGEAL CANCER INCIDENCE ACROSS KEY REGIONS, 2012
  • FIGURE 17: LUNG CANCER INCIDENCE, 2012-2030
  • FIGURE 18: LUNG CANCER INCIDENCE ACROSS KEY REGIONS, 2012
  • FIGURE 19: BREAST CANCER INCIDENCE, 2012-2030
  • FIGURE 20: BREAST CANCER INCIDENCE ACROSS KEY REGIONS, 2012
  • FIGURE 21: BLOOD CANCER INCIDENCE, 2012-2030
  • FIGURE 22: BLOOD CANCER INCIDENCE ACROSS KEY REGIONS, 2012
  • FIGURE 23: NUTRITIONAL FEEDING FORMULAS: MARKET SHARE ASSESSMENT, 2015 VS 2017 VS 2023
目次
Product Code: PH 6225

"The oncology nutrition market is projected to grow at a CAGR of 8.7% between 2018 and 2023."

The oncology nutrition market is expected to reach USD 2.21 billion by 2023 from USD 1.46 billion in 2018, at a CAGR of 8.7%. The overall growth of the market is largely driven by the shifting focus from parenteral to enteral nutrition, increasing incidence of cancer, growing demand for nutritional feeding in the homecare sector, rising number of patients being treated for malnutrition, and increasing quality of clinical research on nutritional interventions. The development of elemental formulas and product innovation in this field also provides significant growth opportunities in this market. However, the complications associated with tube feeding and limited reimbursement represent significant challenges to the market growth.

"The head and neck cancers segment is expected to grow at the fastest rate during the forecast period."

Based on cancer type, the oncology nutrition market is segmented into head & neck cancers, stomach & gastrointestinal cancers, pancreatic cancer, liver cancer, esophageal cancer, lung cancer, breast cancer, blood cancer, and other cancers. The head & neck cancers segment is expected to grow at the highest CAGR during the forecast period. This is primarily attributed to the increasing incidence of head and neck cancers across the globe. Such patients see the major use of feeding formulas as severe conditions such as mucositis, xerostomia, dysgeusia, nausea, and vomiting limit their nutritional intake.

"APAC to witness the highest growth during the forecast period."

Geographically, the oncology nutrition market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2017, North America commanded a major share of the oncology nutrition market. However, Asia Pacific is expected to witness the highest growth during the forecast period. The significant growth of the Asia Pacific market is mainly attributed to the growing prevalence of chronic diseases & disorders, increasing number of preterm births, rising geriatric population, and increasing healthcare expenditure.

Break primary participants:

  • By Company Type - Tier 1: 48%, Tier 2-34%, and Tier 3-18%
  • By Designation - C-suite: 32%, Director and Manager Level: 48%, and Executives and Others: 20%
  • By Region - North America: 36%, Europe: 27%, Asia Pacific: 21%, and the Rest of the World: 16%

The players competing in this market are: Abbott Laboratories (US), Nestle S.A. (Switzerland), Danone (France), Fresenius Kabi AG (Germany), and B.Braun Melsungen AG (Germany). The other players in this market include Mead Johnson Nutrition Company (US), Hormel Foods (US), Meiji Holdings (Japan), Victus (US), and Global Health Products (US).

Research Coverage:

The report analyzes the various types of nutritional formulas for cancer in the market and their adoption patterns. It aims at estimating the market size and future growth potential of the oncology nutrition market for different cancer types and region. The report also includes in-depth company profiles of the key players in this market along with their product offerings, recent developments, and market strategies.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below-mentioned four strategies for strengthening their market position.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the oncology nutrition market
  • Product Development/Innovation: Detailed insights on the research and development activities and new product launches in the oncology nutrition market
  • Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the oncology nutrition market
  • Competitive Assessment: In-depth assessment of growth strategies, products, and manufacturing capabilities of leading players in the oncology nutrition market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET COVERED
  • 1.3. MARKET DEFINITION
  • 1.4. YEARS CONSIDERED

2. RESEARCH METHODOLOGY

  • 2.1. SECONDARY RESEARCH
  • 2.2. PRIMARY RESEARCH
  • 2.3. ANALYSIS

3. MARKET DYNAMICS

  • 3.1. DRIVERS
  • 3.2. RESTRAINTS
  • 3.3. OPPORTUNITIES

4. INDUSTRY INSIGHTS

  • 4.1. CLINICAL CHALLENGES
  • 4.2. MARKET CHALLENGES
  • 4.3. PRODUCT ATTRIBUTES ASSESSMENT
  • 4.4. INSIGHTS OF INDUSTRY EXPERTS

5. GLOBAL ONCOLOGY NUTRITIONAL FEEDING FORMULAS MARKET, BY CANCER TYPE

  • 5.1. OVERVIEW - CANCER
  • 5.2. MARKET SIZE, BY CANCER TYPE
  • 5.3. HEAD AND NECK CANCER
  • 5.4. STOMACH AND GASTROINTESTINAL CANCERS
  • 5.5. LIVER CANCER
  • 5.6. PANCREATIC CANCER
  • 5.7. ESOPHAGEAL CANCER
  • 5.8. LUNG CANCER
  • 5.9. BREAST CANCER
  • 5.10. BLOOD CANCER
  • 5.11. OTHER CANCERS

6. PRODUCT PORTFOLIO ASSESSMENT

7. COMPANY PROFILES (Business Overview, Company Snapshot, Financial Review, Products Offered, Recent Developments, MnM View)*

  • 7.1. ABBOTT LABORATORIES
  • 7.2. NESTLE
  • 7.3. DANONE
  • 7.4. FRESENIUS KABI
  • 7.5. B. BRAUN

8. MARKET SHARE ANALYSIS

Back to Top